We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.43%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.1B
AUM Growth
+$6.94B
(+18%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
995
New
107
Increased
596
Reduced
238
Closed
35
Top Buys
| 1 |
NVIDIA
NVDA
|
+$231M |
| 2 |
Amgen
AMGN
|
+$171M |
| 3 |
Johnson & Johnson
JNJ
|
+$158M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$153M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$142M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$209M |
| 2 |
Broadcom
AVGO
|
+$207M |
| 3 |
TJX Companies
TJX
|
+$195M |
| 4 |
Emerson Electric
EMR
|
+$193M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$171M |
Sector Composition
| 1 | Technology | 27.07% |
| 2 | Healthcare | 17.55% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Mueller Water Products
MWA
$4B
| $149K | ﹤0.01% |
+10,360
| New | +$137K |
|
|
INN
952
Summit Hotel Properties
INN
$713M
| $132K | ﹤0.01% |
19,635
-1,561
| -7% | -$9.61K |
|
|
GRTX
953
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $131K | ﹤0.01% |
+898,374
| New | +$140K |
|
|
AFMD
954
DELISTED
Affimed
AFMD
| $130K | ﹤0.01% |
+20,862
| New | +$86.6K |
|
|
SPWR
955
DELISTED
SunPower Corporation Common Stock
SPWR
| $89.4K | ﹤0.01% |
18,503
+8,432
| +84% | +$40.3K |
|
|
ORKA
956
Oruka Therapeutics
ORKA
$5.45B
| $55.2K | ﹤0.01% |
+2,705
| New | +$60.7K |
|
957
Stem
STEM
$56.6M
| $39.5K | ﹤0.01% |
+509
| New | +$35.1K |
|
|
TUYA
958
Tuya Inc
TUYA
$1.04B
| $24K | ﹤0.01% |
+10,440
| New | +$19.3K |
|
959
FuelCell Energy
FCEL
$1.47B
| $17K | ﹤0.01% |
354
| – | – |
|
960
Alaska Air
ALK
$5.05B
| – | – |
-9,711
| Closed | -$360K |
|
|
ALLK
961
DELISTED
Allakos
ALLK
| – | – |
-131,347
| Closed | -$298K |
|
962
Braze
BRZE
$2.96B
| – | – |
-6,192
| Closed | -$289K |
|
963
Blackstone Mortgage Trust
BXMT
$2.86B
| – | – |
-108,818
| Closed | -$2.37M |
|
964
Certara
CERT
$1.07B
| – | – |
-144,522
| Closed | -$2.1M |
|
965
Sprinklr
CXM
$1.36B
| – | – |
-84,478
| Closed | -$1.17M |
|
966
DXC Technology
DXC
$1.54B
| – | – |
-39,148
| Closed | -$815K |
|
967
National Vision
EYE
$1.69B
| – | – |
-898,983
| Closed | -$14.5M |
|
968
Freshworks
FRSH
$3.01B
| – | – |
-18,259
| Closed | -$364K |
|
969
Fortrea Holdings
FTRE
$1.69B
| – | – |
-14,265
| Closed | -$408K |
|
970
Globus Medical
GMED
$10.4B
| – | – |
-17,690
| Closed | -$878K |
|
971
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.92B
| – | – |
-217,357
| Closed | -$4.61M |
|
972
LCI Industries
LCII
$2.63B
| – | – |
-147,926
| Closed | -$17.4M |
|
973
Monro
MNRO
$528M
| – | – |
-386,646
| Closed | -$10.7M |
|
974
NovoCure
NVCR
$1.86B
| – | – |
-36,339
| Closed | -$587K |
|
975
Envista
NVST
$4.35B
| – | – |
-494,085
| Closed | -$13.8M |
|
Similar funds
Aberdeen Group's Q4 2023 Portfolio in Review
As of Q4 2023, Aberdeen Group held 995 positions worth $46.1B, up 18% from $39.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aberdeen Group deployed $2.24B of net new capital in Q4 2023, opening 107 new positions and adding to 596 existing holdings. Its largest new stake was Veralto: 984,184 shares worth $81M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Microsoft, an estimated $209M trimmed.
- Aberdeen Group's largest Q4 2023 buy was Veralto: 984,184 shares worth $81M.
- Aberdeen Group added most to NVIDIA in Q4 2023, an estimated $231M increase.
- Aberdeen Group's biggest Q4 2023 reduction was Microsoft, cutting an estimated $209M.
- Aberdeen Group fully exited VMware, Inc in Q4 2023, selling an estimated $61M.
- Aberdeen Group's ten largest holdings make up 24% of its $46.1B portfolio in Q4 2023.
- Aberdeen Group opened 107 new positions and closed 35 in Q4 2023.
- Aberdeen Group's portfolio value rose 18% quarter-over-quarter to $46.1B.
Based on Aberdeen Group's 13F filing for Q4 2023, filed 31 Jan 2024.